Aethlon Medical, Inc. (NASDAQ: AEMD) Starts Presentation at LD Micro 2017 Invitational
Aethlon Medical (NASDAQ: AEMD) is a medical device company that focuses on creating devices that address unmet medical needs in cancer, infectious diseases, and other life-threatening conditions in the United States. The company develops Aethlon Hemopurifier, a medical device, which targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. For more information, visit the company's website at www.aethlonmedical.com.…







